| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
CLLS
Cellectis SA
|
May 28, 2026 | BUY |
Strong Buy
+573.5% avg upside
16 analysts
|
$9.00
202.07% Upside
|
· |
|
CYTK
Cytokinetics
|
Dec 21, 2025 | BUY |
Strong Buy
+8.9% avg upside
36 analysts
|
$87.00
10.38% Upside
|
+20.4% |
|
RARE
Ultragenyx Pharmaceutical
|
Nov 24, 2025 | BUY |
Strong Buy
+142.1% avg upside
36 analysts
|
$50.00
82.21% Upside
|
-29.5% |
|
MRNA
Moderna
|
Nov 21, 2025 | HOLD |
Hold
+6.1% avg upside
38 analysts
|
$25.00
60.84% Downside
|
+169.6% |
|
KOD
Kodiak Sciences
|
Nov 17, 2025 | HOLD |
Buy
+37.3% avg upside
11 analysts
|
$17.00
53.03% Downside
|
+80.1% |
|
LEGN
Legend Biotech
|
Nov 13, 2025 | BUY |
Strong Buy
+140.3% avg upside
27 analysts
|
$90.00
222.17% Upside
|
+15.7% |
|
CRSP
Crispr Therapeutics AG
|
Nov 11, 2025 | HOLD |
Buy
+39.1% avg upside
41 analysts
|
$56.00
3.59% Upside
|
-2.0% |
|
VIR
Vir Biotechnology
|
Nov 11, 2025 | BUY |
Strong Buy
+185.4% avg upside
16 analysts
|
$31.00
238.49% Upside
|
+62.9% |
|
EDIT
Editas Medicine
|
Nov 11, 2025 | HOLD |
Buy
+407.9% avg upside
33 analysts
|
$3.00
11.44% Upside
|
-0.6% |
|
FDMT
4D Molecular Therapeutics
|
Nov 10, 2025 | BUY |
Strong Buy
+265.2% avg upside
15 analysts
|
$33.00
241.58% Upside
|
-10.0% |
|
VRTX
Vertex Pharmaceuticals
|
Nov 10, 2025 | HOLD |
Strong Buy
-2.6% avg upside
61 analysts
|
$414.00
8.37% Downside
|
+9.0% |
|
PBYI
Puma Biotechnology
|
Nov 07, 2025 | SELL |
Buy
+458.2% avg upside
11 analysts
|
$2.00
73.51% Downside
|
-14.4% |
|
NTLA
Intellia Therapeutics
|
Nov 07, 2025 | BUY |
Buy
+151.9% avg upside
37 analysts
|
$14.00
10.57% Downside
|
+27.2% |
|
ONC
BeOne Medicines
|
Nov 07, 2025 | BUY |
Strong Buy
+28.4% avg upside
28 analysts
|
$385.00
42.61% Upside
|
-17.9% |
|
RGNX
RegenXBio
|
Nov 07, 2025 | BUY |
Strong Buy
+381.4% avg upside
22 analysts
|
$37.00
374.40% Upside
|
-49.0% |
|
SGMO
Sangamo Therapeutics
|
Nov 07, 2025 | HOLD |
Buy
+5844.2% avg upside
16 analysts
|
$1.00
473.06% Upside
|
-72.3% |
|
SRPT
Sarepta Therapeutics
|
Nov 05, 2025 | HOLD |
Buy
+244.5% avg upside
49 analysts
|
$20.00
14.15% Upside
|
-15.6% |
|
PTCT
PTC Therapeutics
|
Nov 05, 2025 | HOLD |
Buy
-1.5% avg upside
29 analysts
|
$68.00
13.80% Downside
|
+9.4% |
|
BEAM
Beam Therapeutics
|
Nov 05, 2025 | HOLD |
Strong Buy
+50.8% avg upside
25 analysts
|
$21.00
38.46% Downside
|
+27.4% |
|
SLDB
Solid Biosciences
|
Nov 03, 2025 | BUY |
Strong Buy
+90.3% avg upside
23 analysts
|
$9.00
8.03% Upside
|
+33.1% |
|
BCRX
BioCryst
|
Nov 03, 2025 | HOLD |
Strong Buy
+103.3% avg upside
24 analysts
|
$9.00
0.15% Upside
|
+22.9% |
|
ALNY
Alnylam Pharma
|
Oct 31, 2025 | BUY |
Strong Buy
+23.6% avg upside
51 analysts
|
$527.00
89.46% Upside
|
-38.0% |
|
IONS
Ionis Pharmaceuticals
|
Oct 30, 2025 | BUY |
Strong Buy
+13.3% avg upside
43 analysts
|
$95.00
28.18% Upside
|
-1.2% |
|
BMRN
BioMarin Pharmaceutical
|
Oct 28, 2025 | BUY |
Strong Buy
+72.8% avg upside
52 analysts
|
$80.00
46.31% Upside
|
+2.9% |
|
RNA
Atrium Therapeutics, Inc.
|
Aug 07, 2025 | BUY |
Strong Buy
+171.3% avg upside
4 analysts
|
$62.00
389.82% Upside
|
-14.2% |
|
TECX
Tectonic Therapeutic
|
Aug 10, 2023 | BUY |
Strong Buy
+88.0% avg upside
24 analysts
|
$48.00
59.97% Upside
|
-13.8% |
|
ZYME
Zymeworks
|
Dec 22, 2022 | HOLD |
Strong Buy
+40.3% avg upside
25 analysts
|
$9.00
61.18% Downside
|
+11.8% |
|
ARCT
Arcturus Therapeutics
|
Nov 02, 2022 | HOLD |
Buy
+290.9% avg upside
35 analysts
|
$25.00
232.02% Upside
|
-14.2% |
|
MGTX
Meiragtx Holdings
|
May 13, 2022 | BUY |
Strong Buy
+130.4% avg upside
13 analysts
|
$18.00
59.04% Upside
|
-33.8% |
|
DTIL
Precision BioSciences
|
Mar 15, 2022 | BUY |
Strong Buy
+247.1% avg upside
12 analysts
|
$6.00
11.98% Downside
|
-69.6% |
|
TVTX
Travere Therapeutics
|
Jul 30, 2020 | HOLD |
Strong Buy
-16.0% avg upside
22 analysts
|
$21.00
61.96% Downside
|
-33.5% |
|
HALO
Halozyme
|
May 12, 2020 | HOLD |
Strong Buy
-13.7% avg upside
20 analysts
|
$21.00
69.27% Downside
|
+79.6% |
|
ATRA
Atara Biotherapeutics
|
Jun 22, 2017 | BUY |
Buy
+79.6% avg upside
18 analysts
|
$30.00
197.85% Upside
|
+186.4% |
|
ABEO
Abeona Therapeutics
|
Jan 20, 2017 | BUY |
Strong Buy
+195.8% avg upside
17 analysts
|
— | +192.0% |
|
REGN
Regeneron
|
Aug 17, 2016 | HOLD |
Strong Buy
+26.9% avg upside
57 analysts
|
— | +12.7% |
|
QURE
uniQure
|
Jul 22, 2016 | BUY |
Strong Buy
+16.1% avg upside
29 analysts
|
— | +14.2% |
|
PFE
Pfizer
|
Jul 22, 2016 | BUY |
Buy
+34.2% avg upside
45 analysts
|
— | -5.3% |
|
TPST
Tempest Therapeutics
|
Mar 17, 2015 | BUY |
Buy
+1669.9% avg upside
18 analysts
|
$56.00
4452.89% Upside
|
-81.2% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.